The pharmacy market comprises the retail and institutional sale of medications—including generic drugs, branded pharmaceuticals, over-the-counter (OTC) products, and therapeutic services—through outlets such as pharmacies, online platforms, and hospital dispensaries. Generics dominate much of this space, offering chemically equivalent but more affordable alternatives to brand-name drugs, which helps reduce healthcare costs and enhance patient access, especially for managing chronic conditions. Government policies, regulatory frameworks like streamlined approval pathways, and the expiration of patents are vital in expanding generic availability and fueling market growth.
According to Fortune Business Insights, the global pharmacy market was valued at USD 2,051.5 billion in 2023 and is projected to grow from USD 2,187.5 billion in 2024 to USD 3,886.3 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 7.4% during the forecast period. In 2023, North America dominated the market with a 38.26% share.
In June 2024, Infosys Limited entered into a strategic collaboration with Nihon Chouzai (TSE), one of Japan’s leading dispensing pharmacy chains. This alliance enhanced healthcare access across Japan by strengthening online medication services, marking a significant advancement in digital pharmacy capabilities in the region.
Several critical factors are propelling the global pharmacy market forward: